首页> 美国卫生研究院文献>Iranian Journal of Pharmaceutical Research : IJPR >Sensitive Simultaneous Measurement of Metformin and Linagliptin in Plasma Samples by Couple of Nano Graphene Oxide-based Dispersive Solid Phase Extraction Method and Liquid Chromatography
【2h】

Sensitive Simultaneous Measurement of Metformin and Linagliptin in Plasma Samples by Couple of Nano Graphene Oxide-based Dispersive Solid Phase Extraction Method and Liquid Chromatography

机译:纳米石墨烯基三分色散固相萃取法与液相色谱法敏感同时测量血浆样品中的二甲双胍和Linagliptin

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A simple, rapid, and ultra sensitive dispersive solid phase extraction based on nano graphene oxide was developed for simultaneous measurement of trace amounts of metformin (MET) and linagliptin (LIN) in plasma samples by HPLC-UV-Vis. Affecting factors on the extraction of these drugs, including adsorbent weight, extraction time, organic solvent type, desorption situations, and composition of solvent were examined and optimized. In optimum conditions, the LOD (limit of detection) and LOQ (limit of quantification) of the suggested technique were 2.0 ngmL-1 and 6.1 (ngmL-1) for LIN and 3.0 ngmL-1 and 9.2 ngmL-1 for MET, respectively. Suitable linear behavior in the considered ranges of concentration (10-2000 ngmL-1) and good correlation coefficient of 0.9901 and 0.9903 (r2) for LIN and MET were obtained, respectively. The RSD (relative standard deviations) according to three replicate measurements at 2, 20, 200 ngmL-1 levels of these drugs was less than 8.0%. In the last step, applicability of the suggested technique was examined by analyzing the drugs in plasma samples and reasonable results were achieved.
机译:基于纳米石墨烯氧化物的简单,快速和超敏感的分散性固相萃取,用于通过HPLC-UV-Vis同时测量血浆样品中的痕量二甲双胍(Met)和Linagliptin(Lin)。检查这些药物提取的因素,包括吸附重量,提取时间,有机溶剂型,解吸局势和溶剂组合物。在最佳条件下,建议技术的LOD(检测限)和LOQ(量化限制)为LIN的2.0 ngml-1和6.1(NGML-1),分别为3.0 ngml-1和9.2 ngml-1 。所考虑的浓度范围(10-2000 ngml-1)和0.9901和0.9903(R2)的良好浓度范围和良好的线性行为进行了适当的林和0.9903(R2)。根据三种重复测量的RSD(相对标准偏差)在2,20,200ngml-1水平的这些药物中的3级小于8.0%。在最后一步中,通过分析血浆样品中的药物来检查建议技术的适用性,并实现了合理的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号